NCT06978608

Brief Summary

Complex regional pain syndrome (CRPS) is a disorder falling within the sphere of neuropathic pain, characterised by a plethora of symptoms. Regional pain out of proportion to the triggering event is the main presentation, accompanied by allodynia, dysesthesia, thermal asymmetry, trophic changes, oedema and stiffness. Recently, preliminary observational studies have found that the management of patients with CRPS, refractory to pharmacological treatment, by carpal tunnel release may be resolving; This suggests that an irritative carpal tunnel syndrome may be masked as CRPS due to non-specific symptoms and negative electrodiagnostic studies (electromyography-EMG). Classical carpal tunnel syndrome (CTS) is a well-defined clinical condition that can be ascertained by EMG. In contrast, irritative carpal tunnel syndrome has symptoms attributable to CRPS with negative EMG that arises after trauma that required surgery or immobilisation. It is unclear how to define the presence of irritative carpal tunnel syndrome in patients diagnosed as CRPS, and thus how to make a correct diagnosis. Nor is the management of these patients defined. The aim of the research is to analyse all patients with typical symptoms for CRPS to investigate the morphological appearance of the median nerve at the level of the carpal tunnel by means of dynamic ultrasound in comparison with the healthy limb. In addition, in order to quantify the function of the median nerve, investigators will analyse patients by means of a sensory conduction velocity study (SNVC), as common EMG examinations are negative in these patients, while it is possible that the quantification of the sensory part of the nerve may be impaired. In addition, the autonomic component will be investigated by studying the Skin Sudomotor Response (SSR).The hypothesis is that some patients, after an injury that required surgery or immobilisation, develop fibrous soft tissue scarring that creates a kind of space-occupying lesion that compresses the median nerve at the level of the carpal tunnel and reduces its sliding under the transverse ligament of the carpus, a structure that is not elastic and therefore unable to adapt to the volumetric increases within it. The other hypothesis is that the fibrosis and post-traumatic oedema, which is structured, directly involves the median nerve sheath, resulting in irritation. Classical CTS develops due to mechanical trauma, high pressure and ischaemic damage affecting the median nerve and develops as a clinical condition of pure nerve suffering, with symptoms referable to a sensory and motor deficit. In CRPS, on the other hand, allodynia, hyperalgesia, sudomotor and vasomotor abnormalities and trophic changes are all symptoms that may be related, but are not specific, to nerve suffering.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 18, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2026

Completed
Last Updated

May 18, 2025

Status Verified

April 1, 2025

Enrollment Period

25 days

First QC Date

April 23, 2025

Last Update Submit

May 16, 2025

Conditions

Keywords

CRPSMEDIAN NERVECARPAL TUNNELSENSORYULTRASOUNDSOMATOSENSORY

Outcome Measures

Primary Outcomes (1)

  • Number of patients with altered gliding and/or presence of adhesion between the median nerve and the flexor tendons and/or transverse carpal ligament in patients affected by CRPS type I

    Ultrasound examination will be done either to the affected and the contralateral side. The median nerve will be studied in terms of gliding of the nerve , adhesions with the flexor tendons and / or the transverse carpal ligament. The presence of hypertrophy will be addressed by measuring the median nerve thickness.

    Up to 12 months. From date of recruitment until the date of clinical improvement, assessed up to 12 months

Secondary Outcomes (1)

  • Number of patients with altered sensory nerve conduction velocity study in patients affected by CRPS type I

    Up to 12 months. From date of recruitment until the date of clinical improvement, assessed up to 12 months

Study Arms (1)

Patients with Budapest Criteria positive for CRPS type I, older than 18 years old

Any specific symptoms will be recorded. Patients will undergo ultrasound examination to analyze on both the healthy and diseased side the morphological aspect of the median nerve at the carpal tunnel level, to address gliding in terms of mm, adhesion between the transverse ligament and flexor tendons. The aim will be to try to define specific predictive morphological patterns relative to the clinical appearance. Sensory nerve conduction velocity (SNCV) of the median-nerve will be evaluated to analyze the somatosensory part of the median nerve and understand the potential use of this as a diagnostic tool.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population will be enrolled at the primary care clinic of the hospital, diagnosed as CRPS type I.

You may qualify if:

  • patients diagnosed with CRPS assessed at the AOUC's Hand Surgery and Reconstructive Microsurgery SOD
  • Patients aged 18 years and over
  • Signature of informed consent for participation in the study and processing of related data

You may not qualify if:

  • patients suffering from CRPS type II and therefore with known peripheral nerve injury
  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Complex Regional Pain SyndromesMedian Neuropathy

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesMononeuropathies

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2025

First Posted

May 18, 2025

Study Start

September 1, 2025

Primary Completion

September 26, 2025

Study Completion

February 26, 2026

Last Updated

May 18, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share